|
| Monday, April 21, 2014 |
|
|
Finding Small Cap Equities that Grow in All Macro Environments |
| "Small cap companies have outperformed large caps in almost every market cycle," highlights Jane M. White, Co-Founder, President & Chief Executive Officer, Granahan Investment Management, Inc. more info >> |
|
|
The Dos and Don'ts of Reviving Frozen Real Estate Projects in the Middle East |
| As infrastructure and property developers in the Middle East start reviving projects that were put on hold, there are a few things that they need to do differently, according to Ayman Okasha, GM Rental & Mirdiff, Union Properties. more info >> |
|
|
The Second Season of the Chinese Miracle: The New Investment Opportunities Coming Our Way |
| Dr Fan Gang, a speaker at the marcus evans European Pensions & Investments Summit 2014, discusses the upcoming investment opportunities in China. more info >> |
|
| Thursday, April 17, 2014 |
|
|
Why the Infrastructure Investment Opportunities in Latin America Beat Those of Developed Countries |
| As the US and European economies recover, some foreign infrastructure and property investors in Latin America may be tempted to invest back into the stronger economies. more info >> |
|
|
What Pension Fund Investors Could Learn from Adair Turner |
| A drop in interest rates in the past 15 years has induced a "ferocious 'search for yield uplift'", making some pension fund investors "susceptible to claims that clever financial structuring could deliver additional yield without apparent additional risk," according to Adair Turner, Former Chairman, Financial Services Authority (FSA). more info >> |
|
|
Engaging the Four Target Groups in Pharma Today: Why a Coordinated Approach is a Must |
| "Pharmaceutical product marketers have always had to get the target, message and frequency right; that has not changed. However, with healthcare reform, they now have four different groups of targets, each one requiring a different strategy. To be competitive, a coordinated approach is a must," says Leslie C. North, Former Vice President, Marketing, Bayer Healthcare Pharmaceuticals. more info >> |
|
| Monday, March 18, 2013 |
|
|
Japanese Investments Summit 2013: Mapping Out the Next Step for Japanese Investors |
| The Japanese economy seems to be back on the recovery track as domestic demand related to post-quake reconstruction is supporting economic growth. However, the continuing bottlenecks are the ongoing uncertainties in the global economy. more info >> |
|
| Monday, December 3, 2012 |
|
|
Designing the Optimal Family Governance Structure |
| Wealthy families have to be more involved in the investment management process, says David Plyler, Chief Executive Officer and Founder, Gleneagles Group. more info >> |
|
| Thursday, November 29, 2012 |
|
|
Collaboration is the Name of the Game in the Medical Device R&D Industry |
| The medical device manufacturing industry should look towards collaboration to develop cheaper products and to become more specialized in their field, says Raouf Guirguis, Chairman and Chief Executive Officer, Converting Biophile Laboratories, Inc. more info >> |
|
| Wednesday, November 21, 2012 |
|
|
Manufacturing the Appropriate Medical Devices for the Right Market |
| "Medical device manufacturers should invest in gaining a global education. This will give them a true comprehension of the logistics, supply and inventory systems that are the processes that drive the product," says Thomas M. Loarie, Executive Chairman, Mercator MedSystems, Inc. more info >> |
|
|
|
